📂 Everything you need for effective long-range planning—now in one place. https://ow.ly/faXL50VNRvB Our new Long Range Planning Content Hub, which includes thought leadership and practical tools, is designed to support strategic decision-making and help you build a future-ready forecasting approach in the life sciences sector. Access it now at the link in this post.
Evaluate Ltd
Information Services
Evaluate provides trusted commercial intelligence and predictive analytics to the pharmaceutical industry
About us
Evaluate provides trusted commercial intelligence and forecasting models for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global biopharma market to drive better decisions. Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action. Evaluate Pharma - the trusted global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2030, company financials, pipelines, deals and more. Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential. Forecasting Solutions - Ensure precise and efficient forecasting at every stage of your product lifecycle. Our comprehensive suite of forecasting solutions tailored to the pharmaceutical industry, including software, cloud-based platforms, custom-built models, advanced analytics and data. Our forecasting solutions support forecasters through new product planning, launch, and commercialisation. CDMO Intelligence - Access CDMO screening, molecular landscape insights, detailed manufacturing capabilities, and accurate volume forecasts. You’ll have a wealth of data and industry insights at your fingertips, backed by gold standard financial forecast methodologies. Consulting and Analytics - Evaluate’s consulting and analytics team is here to help clients address unique scientific, clinical and commercial challenges. We answer key asset, portfolio strategy, and corporate strategy-related business questions, powered by the combined resources of Norstella, one of the world’s largest pharma intelligence solutions providers. Evaluate’s combination of leading data sources, deep pharma expertise, robust methodologies, data science and real-world data will ensure your teams make the right decisions to drive your growth.
- Website
-
http://www.evaluate.com
External link for Evaluate Ltd
- Industry
- Information Services
- Company size
- 51-200 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 1996
- Specialties
- pharma business analysis, pharma licensing deals, pharma consensus forecasts, biotech business analysis, pharma competitive intelligence, medtech consensus forecasts, pharma business developement, pharma R&D analysis, pharma data, pharma forecasting models, Real World Data, Pharma portfolio strategy, Pharma Consulting, and BD&L consulting
Locations
-
Primary
Get directions
3 More London Riverside
London, SE1 2RE, GB
-
Get directions
60 State St
Boston, Massachusetts 02109, US
-
Get directions
Akasaka Garden City 4F, 4-15-1 Akasaka,
Tokyo, Tokyo 107-0052, JP
Employees at Evaluate Ltd
Updates
-
“Always do the work as if you’re going to commercialize”. This was the advice from Verona Pharma's Chris Martin in our webinar that investigated best practices for biotechs planning to go solo with a product launch. Check out our blog that shares a few highlights from the discussion - and then go and watch the on-demand webinar to get all the detail! https://ow.ly/yspl50VTORe
-
-
The latest quarterly outlook report has arrived from Biomedtracker! Plan for the drugs, deals and catalysts expected to shape Q2 in our latest quarterly outlook report. Download now! https://ow.ly/yl4e50VSUvg
-
🚨 Webinar Alert: https://lnkd.in/eCYyHz42 Join our expert panel of healthcare analysts as they break down the major announcements, clinical trial results and emerging therapies from this year’s ASCO conference. 📅 Date: June 17, 2025 🕒 Time: 3PM BST / 10AM ET 🔗 Register now: https://lnkd.in/eCYyHz42
This content isn’t available here
Access this content and more in the LinkedIn app
-
How did the first quarter of 2025 pan out for the commercial side of pharma? We've crunched the numbers in our new Q1 round up report - the theme is Under Pressure, and you'll see why. Check out the latest trends in M&A, IPOs, and venture financing with data and expert commentary. https://ow.ly/2Ucz50VRI0R
-
-
Calling all ambitious biotechs! This is your last chance to register for our webinar, "Going Solo: What's Driving the Biotech Boost?" Our expert panel, featuring Verona Pharma's CCO, Chris Martin, will investigate the forces that are driving today's biotechs to self-commercialize and discuss the pitfalls and lessons learned from those who've already succeeded. Register now! https://ow.ly/PNrq50VPT21
-
Any biotech that's looking to self-commercialize has got a long - but potentially incredibly rewarding journey ahead of them. Our experts have been examining the human, data and digital forces that are encouraging small players to go solo. Join our team, along with Verona Pharma's Chris Martin as they discuss the potential pitfalls and success strategies for today's ambitious biotechs. https://ow.ly/Tr0j50VPSZP
-
-
Total biopharma financing for 2024 reached $88.6 billion, a 19% increase compared to 2023's total value of $74.2 billion. Discover the breakdown of total money invested in biopharma in 2024 by quarter and deal type in the deal-making report. Download: https://ow.ly/9BlW50VO146
-
-
【📣ウェビナー】Achieve forecasting excellence！ #製薬 企業における長期#売上予測 の最適化戦略を例に 製薬企業の長期計画 (LRP)における売上予測は 、企業の成長と持続可能性を確保するための重要なプロセスです。 しかしながら、 ・予測モデルの一貫性の欠如 ・予測モデルファイルの管理の困難さ ・ステークホルダー間の調整の難しさ ・手動データ集約の非効率性・・・など、LRPには依然として多くの課題が伴います。 本ウェビナーでは、これらの課題に対する解決策として、当社が誇る製薬企業向け売上予測ソリューションの『FC365』を紹介しながら、どのように長期計画 (#LRP ) における予測のプロセスを最適化し、企業の意思決定に活用していくのかを詳細に解説いたします。 ※本ウェビナーは日本語で開催されます。 ✔️5/20（火）15:00より日本語開催 https://lnkd.in/gm4UeNyK
-